Increasing Incidence of Type 1 and Type 2 Diabetes Among Canadian Children.


Journal

Canadian journal of diabetes
ISSN: 2352-3840
Titre abrégé: Can J Diabetes
Pays: Canada
ID NLM: 101148810

Informations de publication

Date de publication:
Mar 2022
Historique:
received: 22 04 2021
revised: 13 07 2021
accepted: 14 08 2021
pubmed: 2 2 2022
medline: 12 4 2022
entrez: 1 2 2022
Statut: ppublish

Résumé

Diabetes mellitus is one of the most common pediatric chronic illnesses. Although a rising incidence of childhood type 1 diabetes (T1D) has frequently been documented, an almost 400-fold variation in incidence has been seen worldwide. We aimed to describe the trends in incidence of diabetes (type 1, type 2, all types) among children and adolescents living in the Greater Montréal area of Québec, Canada. Using health administrative data (Québec Integrated Chronic Disease Surveillance System) and medical records from the 3 major pediatric diabetes centres in the Greater Montréal area, we conducted serial cross-sectional studies of children aged 1 to 15 years during the period from 2002 to 2010. We conducted a trend analysis of diabetes incidence over time using multivariate Poisson regression models. We identified 696 new cases of diabetes between 2002 and 2010. The age-standardized incidence of diabetes (all types) increased from 16.3 (95% confidence interval [CI], 12.4 to 21.2) to 27.8 (95% CI, 22.5 to 34.0) per 100,000, with annual incidence increasing, on average, by 5.2% per year (adjusted rate ratio [aRR], 1.052; 95% CI, 1.022 to 1.083). This was driven predominantly by the T1D annual increase of 5.4% (aRR, 1.054; 95% CI, 1.023 to 1.086). A low number of incident cases of type 2 diabetes limited trend analysis in this group. There were no significant interactions between year and sex or age. The annual incidence of T1D is increasing in Québec children and does not vary by sex or age. Further research into etiologic factors is indicated.

Sections du résumé

BACKGROUND BACKGROUND
Diabetes mellitus is one of the most common pediatric chronic illnesses. Although a rising incidence of childhood type 1 diabetes (T1D) has frequently been documented, an almost 400-fold variation in incidence has been seen worldwide. We aimed to describe the trends in incidence of diabetes (type 1, type 2, all types) among children and adolescents living in the Greater Montréal area of Québec, Canada.
METHODS METHODS
Using health administrative data (Québec Integrated Chronic Disease Surveillance System) and medical records from the 3 major pediatric diabetes centres in the Greater Montréal area, we conducted serial cross-sectional studies of children aged 1 to 15 years during the period from 2002 to 2010. We conducted a trend analysis of diabetes incidence over time using multivariate Poisson regression models.
RESULTS RESULTS
We identified 696 new cases of diabetes between 2002 and 2010. The age-standardized incidence of diabetes (all types) increased from 16.3 (95% confidence interval [CI], 12.4 to 21.2) to 27.8 (95% CI, 22.5 to 34.0) per 100,000, with annual incidence increasing, on average, by 5.2% per year (adjusted rate ratio [aRR], 1.052; 95% CI, 1.022 to 1.083). This was driven predominantly by the T1D annual increase of 5.4% (aRR, 1.054; 95% CI, 1.023 to 1.086). A low number of incident cases of type 2 diabetes limited trend analysis in this group. There were no significant interactions between year and sex or age.
CONCLUSIONS CONCLUSIONS
The annual incidence of T1D is increasing in Québec children and does not vary by sex or age. Further research into etiologic factors is indicated.

Identifiants

pubmed: 35101343
pii: S1499-2671(21)00226-4
doi: 10.1016/j.jcjd.2021.08.006
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

189-195

Informations de copyright

Copyright © 2021 Canadian Diabetes Association. Published by Elsevier Inc. All rights reserved.

Auteurs

Alexandra Cohen (A)

Faculty of Medicine and Health Sciences, McGill University, Montréal, Québec, Canada.

Elise Mok (E)

Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.

Marc Simard (M)

Institut National de Santé Publique du Québec, Québec City, Québec, Canada.

Marjolaine Dubé (M)

Institut National de Santé Publique du Québec, Québec City, Québec, Canada.

Isabelle Larocque (I)

Institut National de Santé Publique du Québec, Québec City, Québec, Canada.

Celine Plante (C)

Institut National de Santé Publique du Québec, Québec City, Québec, Canada.

Laurent Legault (L)

Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada; Department of Pediatrics, Division of Endocrinology, Montréal Children's Hospital, Montréal, Québec, Canada.

Céline Huot (C)

Department of Pediatrics, Division of Endocrinology, Centre hospitalier universitaire Sainte-Justine, Montréal, Québec, Canada.

Sarah Wafa (S)

Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada.

Elham Rahme (E)

Department of Medicine, Division of Clinical Epidemiology, McGill University, Montréal, Québec, Canada.

Meranda Nakhla (M)

Center for Outcomes Research and Evaluation, Research Institute of the McGill University Health Centre, Montréal, Québec, Canada; Department of Pediatrics, Division of Endocrinology, Montréal Children's Hospital, Montréal, Québec, Canada. Electronic address: meranda.nakhla@mcgill.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH